A crossover study of a traditional Asian medicine for Huntington's disease
A crossover study of a traditional Asian medicine for Huntington's disease
批准号:
21591107
负责人:
IWASAKI Koh
金额:
$2.83万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011
中文摘要
对亚洲传统草药Yokukansan(YKS)进行了双向交叉研究,以治疗亨廷顿病(HD)。YKS的总统一亨廷顿病评分量表、最大舞蹈症、最大肌张力障碍有改善的趋势。
英文摘要
A two-way crossover study of a traditional Asian herbal medicine yokukansan(YKS) was conducted for Huntington's disease(HD). YKS showed a tendency for improvement of Total Unified Huntington's Disease Rating Scale, Maximal Chorea, and Maximal Dystonia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yokukansan, a traditional Japanese medicine, ameliorates memory disturbance and abnormal social interaction with anti-aggregation effect of cerebral amyloidβproteins in amylod precursor protein transgenic mice
日本传统药物抑肝散通过抗淀粉样蛋白前体蛋白转基因小鼠脑淀粉样蛋白聚集作用改善记忆障碍和异常社交互动
DOI:
--
发表时间:
2011
期刊:
Neuroscience
影响因子:
3.3
作者:
[Fujiwara H, Takayama S, Iwasaki K, Tabuchi M, Yamaguchi T, Sekiguchi K, Ikarashi Y, Kudo Y, Kase Y, Arai H, and Yaegashi N]
通讯作者:
and Yaegashi N
DOI:
10.1016/j.neuroscience.2011.01.064
发表时间:
2011-04-28
期刊:
NEUROSCIENCE
影响因子:
3.3
作者:
[Fujiwara, H., Takayama, S., Yaegashi, N.]
通讯作者:
Yaegashi, N.
A crossover study of a traditional Asian herbal medicine for Hutington's diseasePoster presentation
传统亚洲草药治疗赫廷顿病的交叉研究海报展示
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Iwasaki K, et at]
通讯作者:
et at
Efficacy and safety of yokukansan, a traditional Asian medicine, for BPSD in Dementia with Lewy Bodies
传统亚洲药物抑肝散治疗路易体痴呆症 BPSD 的功效和安全性
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Iwasaki K, et at]
通讯作者:
et at
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[K.Iwasaki, A.Kikuchi]
通讯作者:
A.Kikuchi
共 6 条
A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients.
-
批准号:17590592
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.73万
-
财政年份:2005
-
负责人:IWASAKI Koh
-
依托单位:
海外基金